Skip to main content
editorial
. 2015 Aug 3;26(10):2010–2011. doi: 10.1093/annonc/mdv332

Figure 1.

Figure 1.

A schematic for biological sample collection throughout the course of disease and treatment. TILs, tumour-infiltrating lymphocytes; cfDNA, cell-free tumour DNA; PBMCs, peripheral mononuclear blood cells; PK, pharmacokinetic; PD, pharmacodynamic; PDX, patient-derived xenograft.